Effect of the new dopaminergic agonist CV 205–502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas (Q44342429)
Jump to navigation
Jump to search
scientific article published on January 1, 1991
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of the new dopaminergic agonist CV 205–502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas |
scientific article published on January 1, 1991 |
Statements
1 reference
Effect of the new dopaminergic agonist CV 205–502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas (English)
Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas (English)
L. Duranteau
P. Chanson
A. Lavoinne
S. Horlait
J. Lubetzki
1 January 1991
1 reference
1 reference
34
1 reference
1
1 reference
25-29
1 reference
Identifiers
1 reference
1 reference